DKSH continued its trajectory of sustainable and profitable growth and delivered further value for its stakeholders in 2024. Driven by accelerated growth in the second half, net sales reached CHF 11.1 billion (+4.0% at CER) and Core EBIT amounted to CHF 343.1 million (+8.4% at CER), resulting in a Core EBIT margin increase of more than 10 basis points to 3.1%.

Free Cash Flow remained high at CHF 256.5 million and Core profit after tax increased to CHF 225.7 million (+13.9% at CER).

DKSH CEO, Stefan P. Butz, said: “I am delighted to report that in 2024, DKSH further advanced on its consistent path of growth, margin expansion and cash conversion. All Business Units contributed  both to net sales and Core EBIT growth (at CER) in a challenging market environment. Thanks to our highly committed and valued employees across all markets, we remained the trusted partner for our clients and customers and continued to fulfill our purpose of enriching people’s lives. We expect to continue to grow Core EBIT in 20253 and reiterate our mid-term roadmap.”

Changes to DKSH’s Board of Directors

On March 27, 2025, DKSH will host its 92nd Annual General Meeting in Zurich. Dr. Hans Christoph Tanner, who joined the Board of Directors in 2011, will not stand for re-election. The Board of Directors thanks Dr. Hans Christoph Tanner for his longstanding and valuable contributions and wishes him all the best in his future endeavors. The Board of Directors will propose Suwannee Ratthayabandith as a new member. She was Managing Director of Thai Union Life Science, a subsidiary of Thai Union, a major global frozen seafood company, from 2020 to 2024. She has more than 25 years of international experience in the consumer goods industry, having held various leading positions within Beiersdorf and Bristol Myers Squibb. Suwannee Ratthayabandith has no significant business relationship with DKSH Holding Ltd. or any other Group company and is therefore considered independent.

Outlook Confirmed

DKSH is committed to its mid-term roadmap, highlighting that its outlook for 2025 aligns with these goals. The company expects Core EBIT in 2025 to be higher than in 2024. This outlook assumes economic growth in Asia Pacific, constant exchange rates, and barring any unforeseen events. The Group remains confident about Asia Pacific's long-term potential and is well-positioned to benefit from favorable market, industry, and M&A consolidation trends.